Platelet-Rich Fibrin vs. Tranexamic Acid for Melasma
Treatments studied
Part of Skin clinical trials.
This trial tests two injectable treatments for melasma (dark patches on the face): platelet-rich fibrin, which uses your own blood cells to promote healing, and tranexamic acid, a medication that may reduce pigmentation. The study will compare which works better for women with mild to moderate melasma.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female, aged 18–50 years old
- You have melasma (dark facial patches) that is bilateral and symmetrical, and mild to moderate in severity
- Your skin type is Fitzpatrick III or IV (medium to olive/dark brown skin)
- You have not had melasma-specific treatment in the past 4 weeks
- You have not had facial procedures (peeling, laser, or microneedling) in the past 3 months
- You are not pregnant, not planning to become pregnant, and not breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a medicine called tranexamic acid, taken as a pill or used on the skin, can help fade melasma in women with darker skin types. It aims to find a safe way to improve skin color and is relevant to those looking for new melasma treatment options. The trial compares the treatment to another study treatment without medicine. Participation is open to women aged 30 to 60 with darker skin tones who are not pregnant and are not using certain other skin or hormone treatments.
This study compares two treatments for melasma: injecting tranexamic acid into the skin versus applying a mandelic acid facial peel. The goal is to see which one works better at lightening the dark patches on your face.
This trial tests whether taking tranexamic acid (a medicine that helps reduce pigmentation) along with a skin treatment called microneedling is more effective for treating melasma than microneedling alone. It aims to help women with facial melasma achieve clearer, more even skin tone.
This study compares two topical creams — one with tranexamic acid and one with vitamin C (ethyl ascorbic acid) — to see which works better for treating melasma. If you have melasma and meet the health criteria, you may be able to join and receive one of these treatments.
This study tests whether adding an oral medicine (tranexamic acid) to a standard triple cream works better for melasma than the cream alone. It may help lighten dark patches on your skin if you have the right type of melasma.
This study compares two creams — metformin and tranexamic acid — to see which works better for melasma (dark patches on the face). If you qualify, you'll use one of the creams and your progress will be checked over time.
Hear when a new Melasma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.